235.00MMarket Cap-5586P/E (TTM)
16.150High14.480Low220.89KVolume15.060Open15.330Pre Close3.41MTurnover3.33%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.71P/B104.81MFloat Cap12.49052wk Low--Dividend TTM6.63MShs Float1115.000Historical High--Div YieldTTM10.89%Amplitude7.500Historical Low15.428Avg Price1Lot Size
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet